Darshan Parikh
13Patents
6h-index
17Co-inventors
55Inventor score
Filing activity: Apr 16, 2014 → Sep 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9359364B2 | Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one | Chemistry; Metallurgy | 11 | Active |
| USD787042S1 | Pharmaceutical tablet | General | 10 | Active |
| USD787043S1 | Pharmaceutical tablet | General | 9 | Active |
| USD835258S1 | Pharmaceutical tablet | General | 7 | Active |
| USD813372S1 | Pharmaceutical tablet | General | 6 | Active |
| USD835257S1 | Pharmaceutical tablet | General | 6 | Active |
| USD858741S1 | Pharmaceutical tablet | General | 5 | Active |
| US10080801B2 | Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione | Emerging Cross-Sectional Technologies | 2 | Active |
| US9468605B2 | Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | Human Necessities | 1 | Active |
| US9364475B2 | Tablet formulation of a phosphatidylinositol 3-kinase inhibitor | Human Necessities | 1 | Active |
| US11389454B2 | Tablet compositions | Human Necessities | 0 | Active |
| US10052322B2 | Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one | Chemistry; Metallurgy | 0 | Active |
| USRE49647E1 | Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.